Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes using disease-related blood biomarkers
Published inArthritis and Rheumatology, vol. 73, no. 10, p. 1791-1799
Publication date2021
Abstract
Keywords
- Adolescent
- Adult
- Aged
- Aged
- 80 and over
- Biomarkers / blood
- COVID-19 / blood
- COVID-19 / complications
- COVID-19 / diagnosis*
- Cytokine Release Syndrome / blood
- Cytokine Release Syndrome / etiology*
- Diagnosis
- Differential
- Female
- Humans
- Interleukin-18 / blood*
- Interleukin-8 / blood*
- Lymphohistiocytosis
- Hemophagocytic / blood
- Lymphohistiocytosis
- Hemophagocytic / complications
- Lymphohistiocytosis
- Hemophagocytic / diagnosis*
- Macrophage Activation Syndrome / blood
- Macrophage Activation Syndrome / complications
- Macrophage Activation Syndrome / diagnosis*
- Male
- Middle Aged
- Young Adult
Affiliation entities
Research groups
Citation (ISO format)
KESSEL, Christoph et al. Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes using disease-related blood biomarkers. In: Arthritis and Rheumatology, 2021, vol. 73, n° 10, p. 1791–1799. doi: 10.1002/art.41763
Main files (1)
Article (Published version)
Identifiers
- PID : unige:157650
- DOI : 10.1002/art.41763
- PMID : 33880885
Commercial URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251089/
Journal ISSN2326-5191